Lv1
36 积分 2023-04-20 加入
Unraveling regorafenib resistance: metabolic reprogramming, tumor plasticity, and novel approaches to overcome therapy failure
12小时前
已完结
ZNF207-driven PRDX1 lactylation and NRF2 activation in regorafenib resistance and ferroptosis evasion
14小时前
已完结
APM-Related gene signature model to predict prognosis and immunotherapy response in hepatocellular carcinoma
28天前
已完结
Flavokawain A Targets CXCR4 ‐Mediated Vasculogenic Mimicry to Reverse Hepatocellular Carcinoma Resistance to Tyrosine Kinase Inhibitors
1个月前
已完结
FAM72 family members serves as prognostic biomarker in liver hepatocellular carcinoma
4个月前
已完结
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy
5个月前
已完结
皖公网安备34019202002308
